<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="13411">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02084407</url>
  </required_header>
  <id_info>
    <org_study_id>DM1-Fibroblasts</org_study_id>
    <nct_id>NCT02084407</nct_id>
  </id_info>
  <brief_title>Induction of Pluripotent Stem Cells From Human Fibroblasts of DM1 Patients</brief_title>
  <official_title>Induction of Pluripotent Stem Cells From Human Fibroblasts of DM1 Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut de Myologie, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut de Myologie, France</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is the modelisation of human cardiomyocyts from pluripotent stem
      cells in order to study the cardiac alterations induced by CTG expansions.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Measure of DM1 alterations in human cardiomyocytes derived from induced pluripotent stem cells</measure>
    <time_frame>At baseline</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Molecular changes in human DM1 cardiomyocytes expressing pathogenic CUGexp-RNA</measure>
    <time_frame>At baseline</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>DM1</condition>
  <arm_group>
    <arm_group_label>DM1 subject with cardiopathy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Clinical examination, Skin biopsy, Blood and urine sampling</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DM1 subject without cardiopathy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Clinical examination, Skin biopsy, Blood and urine sampling</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Not DM1subject</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Clinical examination, Skin biopsy, Blood and urine sampling</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Clinical examination, skin biopsy, blood and urine sampling</intervention_name>
    <arm_group_label>DM1 subject with cardiopathy</arm_group_label>
    <arm_group_label>DM1 subject without cardiopathy</arm_group_label>
    <arm_group_label>Not DM1subject</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria for DM1 patient with cardiomyopathy:

          -  aged 20-50

          -  DM1 confirmed by molecular analysis

          -  Confirmed cardiomyopathy (infrahissiens conduction disorders)

          -  able to sign the consent form

          -  affiliated to european social security.

        Inclusion Criteria for DM1 patient without cardiomyopathy

          -  aged 20-50

          -  DM1 confirmed by molecular analysis

          -  No cardiomyopathy (no infrahissiens conduction disorders or other trouble linked to
             DM1)

          -  able to sign the consent form

          -  affiliated to european social security.

        Inclusion Criteria for controls

          -  aged over 18

          -  brother, sister, father or mother of the DM1 patient

          -  No DM1 confirmed by molecular analysis (CTG repetition under 38)

          -  No cardiac disorders.

          -  able to sign the consent form

          -  affiliated to european social security.

        Exclusion Criteria:

          -  no pragnant or nursing women

          -  patient unable to understand informed consent

          -  patient under juridic protection
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laurent Servais, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Myology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laurent Servais, MD PhD</last_name>
    <phone>+33142166647</phone>
    <email>l.servais@institut-myologie.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Karim Wahbi, MD PhD</last_name>
    <phone>+33142163775</phone>
    <email>karim.wahbi@psl.aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institute of Myology</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 7, 2014</lastchanged_date>
  <firstreceived_date>March 4, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>DM1</keyword>
  <keyword>Cardiopathy</keyword>
  <keyword>Adult</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
